Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 616-466-9 | CAS number: 77501-63-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
- Principles of method if other than guideline:
- The modified Local Lymph Node Assay (IMDS) was performed on 24 female NMRI mice of the strain Crl:NMRI BR (6 animals/test item group and 6 control animals) to determine if there is any specific (sensitizing) or non-specific (irritant) stimulating potential of the test item Lactofen.
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- (2-ethoxy-1-methyl-2-oxoethyl)-5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate
- EC Number:
- 616-466-9
- Cas Number:
- 77501-63-4
- Molecular formula:
- C19H15ClF3NO7
- IUPAC Name:
- (2-ethoxy-1-methyl-2-oxoethyl)-5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate
- Test material form:
- other: liquid
- Details on test material:
- Test item: Lactofen
CAS No.: 77501-63-4
Chemical name: (2-ethoxy-1-methyl-2-oxoethyl)-5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate
Content: 95.54%
Empirical formula: C19H15ClF3NO7
Molecular mass: 461.8 g/mol
Physical state: liquid (at arrival)
Appearance: brown
Storage: room temperature
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- female
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Group 1 Vehicle (A/OO = acetone/olive oil)
Group 2 2 % Lactofen (in A/OO)
Group 3 10 % Lactofen (in A/OO)
Group 4 50 % Lactofen (in A/OO)
Group 5 3, 10, 30 % Alpha Hexyl Cinnamic Aldehyde (in A/OO) - No. of animals per dose:
- 6 animals/test item group and 6 control animals
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- A modified Local Lymph Node Assay (IMDS) was carried out in mice. The modifications refer to the measurement of cell proliferation by cell counting instead of radioactive labeling. In addition, the acute inflammatory skin reaction is determined to discriminate specific from non-specific activation of immune competent cells in the draining lymph nodes, as also recommend in the update of OECD TG 429. Direct LLNA (NMRI mice, female, 6 animals/group) Dose [%] Weight index Cell count index (index of mean +/-SD in %) 0 1.00 +/- 13.85 1.00 +/- 22.34 2 0.88 +/- 24.90 1.06 +/- 25.06 10 1.18 +/- 21.42 1.07 +/- 24.80 50 0.99 +/- 16.42 1.04 +/- 21.30 Ear swelling (NMRI mice, female, 6 animals/group, in 0.01 mm) Dose [%] day 1 day4 Index day4 (mean +/- SD in %) 0 17.50 +/- 2.98 17.50 +/- 2.98 1.00 2 17.67 +/- 3.69 17.50 +/- 4.56 1.00 10 17.83 +/- 2.18 17.92 +/- 5.03 1.02 50 17.92 +/- 2.87 18.67 +/- 5.75 1.07 Ear weight (NMRI mice, female, 6 animals/group, in mg per 8 mm diameter punch) Dose [%] day4 Index day4 (mean +/- SD in %) 0 11.20 +/- 6.51 1.00 2 11.53 +/- 8.58 1.03 10 11.51 +/- 6.84 1.03 50 11.65 +/- 7.85 1.04 Group 1 Vehicle (A/OO = acetone/olive oil) Group 2 2 % Lactofen (in A/OO) Group 3 10 % Lactofen (in A/OO) Group 4 50 % Lactofen (in A/OO) Group 5 3, 10, 30 % Alpha Hexyl Cinnamic Aldehyde (in A/OO)
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: not applicable
Any other information on results incl. tables
Stimulation indices (weight and cell counts; ear swelling and ear weight)
Based on results obtained in validation studies and general experiences with this test system groups of mice were treated with vehicle, 2 %, 10% or 50% Lactofen in acetone/olive oil (A/OO).
The NMRI mice did not show an increase in the stimulation indices for cell counts or for weights of the draining lymph nodes after application of the test item Lactofen.
The "positive level", which is 1.4 for the cell count index, was never reached or exceeded in any dose group.
The "positive level" of ear swelling, which is 2xl0E-2 mm increase, i.e. about 10% of the control values, has not been reached or exceeded in any dose group.
A slight significant increase compared to vehicle treated animals regarding ear swelling was detected in the high dose group. However, this change was in the range of normal variance for this parameter and did not exceed the cut-off level (cf. above). No increase in the ear weights were observed in any dose group.
It has to be clarified that the "positive levels" mentioned above are exclusively defined for the NMRI outbred mice used for this study. Such positive limits have to be calculated for each strain of mice individually.
Body weights
The body weights of the animals were not affected by any treatment.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Executive summary:
The modified Local Lymph Node Assay (lMDS) was performed on 24 female NMRI mice of the strain Hsd Win:NMRI (6 animals/ test item group and 6 control animals) to determine if there is any specific (sensitizing) or non-specific (irritating) stimulating potential
of the test item Lactofen.
The study was conducted according to OECD Guideline No. 429, No. 406, EC Guideline 96/54/EC (22nd Adaptation of Guideline 67/548/EEC)/Health Effects Test Guideline, OPPTS 870.2600 (EPA) with the following test item concentrations: 0 (vehicle control), 2, 10 and 50%.
The test item was formulated in Acetone/Olive Oil (4: 1) (A/OO) to yield a solution.
Compared to vehicle treated animals none of the parameter measured, i.e. cell counts and weights of the draining lymph nodes, ear weights and ear swelling reached or exceeded the "positive levels" defined for this assay. These results show that there is no indication
for a skin sensitizing effect after administration of a concentration of up to 50% Lactofen in this test system.
A slight significant increase compared to vehicle treated animals regarding ear swelling was detected in the high dose group. No increase was determined for the ear weights in any dose group.
In conclusion, these results show that the test item (Lactofen) was negative in mice after dermal application of up to and including a 50% concentration. No indication for a non-specific (irritating) activation was detected, too. Therefore, the concentration of 50% turned out to be the NOEL for the parameters investigated in this study with respect to skin sensitization.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
